等等,马克·扎克伯格变成了“肌肉男”?这位在哈佛大学宿舍里发明了Facebook的CEO,似乎从来没有走出过大学校园,他不是瘦骨嶙峋吗?
但他现在早已不是这种形象。追求健康和身材苗条在职场上日益流行,从扎克伯格到杰夫·贝佐斯等科技界大亨纷纷炫耀他们的腹肌,而且服用Ozempic等药物减肥越来越多地变成了人们在茶余饭后谈论的话题。与此同时,许多研究和统计数据表明,因为体重遭到歧视的现象较为普遍。
对健身的痴迷和体重歧视这两种现象的存在,显示出“恐肥症”即对超重者的反感、敌意或蔑视依旧存在,这导致人们在职场中难以公平地获得成功的机会。
据美国疾病预防控制中心(Centers for Disease Control and Prevention)统计,美国肥胖人口约占42%,《美国公共健康杂志》(American Journal of Public Health)新发表的一篇论文将美国体重歧视的普遍性,与种族歧视问题相提并论。
《华尔街日报》在7月关于一项春季调查的报道称,体重歧视对职场女性的影响最为严重:11%的人力资源主管表示,求职者的体重是影响他们是否决定录用的因素之一。范德堡大学(Vanderbilt University)2014年的一项研究显示,肥胖女性的时薪比正常体重的女性少5.25美元。
体重对工资的影响在男性当中的表现不太一致,但总体而言,超重或肥胖员工的收入更低,而且在有晋升机会时经常被忽视。
各州和城市政府正在采取措施减少体重歧视在职场的影响。
与体重有关的污名
肥胖症被许多组织认定为一种体内脂肪过多的疾病。梅奥诊所(Mayo Clinic)表示,肥胖症会增加患其他疾病的风险,会导致心脏病、糖尿病和某些类型癌症等健康问题。
人们之所以很难减肥,可能有许多原因。有些人有肥胖的遗传基因,也有人因为基础病导致体重增加。
“恐肥症”依旧常见。肥胖者经常因为体重遭到指责,并且被冠上懒惰或意志不坚定的污名。有一种依旧存在的普遍观点是,身材羞辱只要能激励人们采取更健康的行为,那就是合理的行为。
纽约市在5月通过了一项法案,在就业机会、住房机会和获取公共住房等方面禁止体重和身高歧视,将其与种族、性别、年龄、宗教和性取向歧视并列。这项新法律将于2023年11月生效。
纽约市市长埃里克·亚当斯在签署法案的仪式上表示:“当你找工作、到市中心游玩或者想租一套公寓的时候,你的身高或体重并不重要。这项法律有助于为所有纽约市民创造一个公平的竞争环境,营造更具包容性的职场和生活环境,并防止歧视。”
新泽西州和马萨诸塞州正在考虑类似的法案。密歇根州、华盛顿州和华盛顿特区等城市已经禁止体重歧视。
肌肉发达的CEO们和减肥药Ozempic
与此同时,已过壮年的公司领导者们确立的身体素质的标杆,需要大量资源才能达到。
达拉斯独行侠队(Dallas Mavericks)老板、商人马克·库班对《华尔街日报》表示:“我认为疫情和居家办公为高管们创造了专心健身的机会。”
他们不再想游艇和劳力士(Rolexes)。库班表示,能在已经很紧张的日程中挤出锻炼的时间,可以作为新的吹牛资本。
例如,Meta联合创始人兼CEO马克·扎克伯格在疫情期间练习巴西柔术,在5月的一次锦标赛中赢得了金牌和银牌。
最近,他在阵亡将士纪念日参加了“墨菲挑战”。该项挑战是为了纪念美国海豹突击队军官在阿富汗遇害。这项挑战要求身穿20磅重的马甲,完成100个引体向上、200个俯卧撑、300个深蹲和一英里跑步。
扎克伯格在40分钟内完成了挑战。之后他在Instagram上将这件事分享给了1,230万粉丝。
其他科技和金融业精英以及好莱坞明星都在用药物减肥。
其中最常用的减肥药Ozempic,被用于帮助2型糖尿病患者降低血糖。Ozempic中含有一种名为赛格列酮的成分,可以刺激胰岛素的分泌和降低食欲。它是最常给肥胖症或超重患者开的药物。
真人秀节目《为百万富翁做媒》(The Millionaire Matchmaker)的制片人和明星帕蒂·斯坦格对《华尔街日报》表示:“这种药物在好莱坞很流行。我身边的人都在服用。”
美国食品药品管理局(FDA)尚未批准Ozempic用于减肥,但人们却依旧能够买到这种药物。如果没有保险,这种药一个月用量的费用约为900美元。同类药物Wegovy已被批准用于减肥,如果没有保险,28天用量的费用超过1,300美元。
埃隆·马斯克在10月发推文称,他正在服用Wegovy和断食减肥。几个与前,他赤裸上身与肌肉发达的明星经纪人阿里·伊曼纽尔并排站在游艇上的照片曝光,这让他经历了一番肥胖羞辱。
翻译:刘进龙
审校:汪皓
等等,马克·扎克伯格变成了“肌肉男”?这位在哈佛大学宿舍里发明了Facebook的CEO,似乎从来没有走出过大学校园,他不是瘦骨嶙峋吗?
但他现在早已不是这种形象。追求健康和身材苗条在职场上日益流行,从扎克伯格到杰夫·贝佐斯等科技界大亨纷纷炫耀他们的腹肌,而且服用Ozempic等药物减肥越来越多地变成了人们在茶余饭后谈论的话题。与此同时,许多研究和统计数据表明,因为体重遭到歧视的现象较为普遍。
对健身的痴迷和体重歧视这两种现象的存在,显示出“恐肥症”即对超重者的反感、敌意或蔑视依旧存在,这导致人们在职场中难以公平地获得成功的机会。
据美国疾病预防控制中心(Centers for Disease Control and Prevention)统计,美国肥胖人口约占42%,《美国公共健康杂志》(American Journal of Public Health)新发表的一篇论文将美国体重歧视的普遍性,与种族歧视问题相提并论。
《华尔街日报》在7月关于一项春季调查的报道称,体重歧视对职场女性的影响最为严重:11%的人力资源主管表示,求职者的体重是影响他们是否决定录用的因素之一。范德堡大学(Vanderbilt University)2014年的一项研究显示,肥胖女性的时薪比正常体重的女性少5.25美元。
体重对工资的影响在男性当中的表现不太一致,但总体而言,超重或肥胖员工的收入更低,而且在有晋升机会时经常被忽视。
各州和城市政府正在采取措施减少体重歧视在职场的影响。
与体重有关的污名
肥胖症被许多组织认定为一种体内脂肪过多的疾病。梅奥诊所(Mayo Clinic)表示,肥胖症会增加患其他疾病的风险,会导致心脏病、糖尿病和某些类型癌症等健康问题。
人们之所以很难减肥,可能有许多原因。有些人有肥胖的遗传基因,也有人因为基础病导致体重增加。
“恐肥症”依旧常见。肥胖者经常因为体重遭到指责,并且被冠上懒惰或意志不坚定的污名。有一种依旧存在的普遍观点是,身材羞辱只要能激励人们采取更健康的行为,那就是合理的行为。
纽约市在5月通过了一项法案,在就业机会、住房机会和获取公共住房等方面禁止体重和身高歧视,将其与种族、性别、年龄、宗教和性取向歧视并列。这项新法律将于2023年11月生效。
纽约市市长埃里克·亚当斯在签署法案的仪式上表示:“当你找工作、到市中心游玩或者想租一套公寓的时候,你的身高或体重并不重要。这项法律有助于为所有纽约市民创造一个公平的竞争环境,营造更具包容性的职场和生活环境,并防止歧视。”
新泽西州和马萨诸塞州正在考虑类似的法案。密歇根州、华盛顿州和华盛顿特区等城市已经禁止体重歧视。
肌肉发达的CEO们和减肥药Ozempic
与此同时,已过壮年的公司领导者们确立的身体素质的标杆,需要大量资源才能达到。
达拉斯独行侠队(Dallas Mavericks)老板、商人马克·库班对《华尔街日报》表示:“我认为疫情和居家办公为高管们创造了专心健身的机会。”
他们不再想游艇和劳力士(Rolexes)。库班表示,能在已经很紧张的日程中挤出锻炼的时间,可以作为新的吹牛资本。
例如,Meta联合创始人兼CEO马克·扎克伯格在疫情期间练习巴西柔术,在5月的一次锦标赛中赢得了金牌和银牌。
最近,他在阵亡将士纪念日参加了“墨菲挑战”。该项挑战是为了纪念美国海豹突击队军官在阿富汗遇害。这项挑战要求身穿20磅重的马甲,完成100个引体向上、200个俯卧撑、300个深蹲和一英里跑步。
扎克伯格在40分钟内完成了挑战。之后他在Instagram上将这件事分享给了1,230万粉丝。
其他科技和金融业精英以及好莱坞明星都在用药物减肥。
其中最常用的减肥药Ozempic,被用于帮助2型糖尿病患者降低血糖。Ozempic中含有一种名为赛格列酮的成分,可以刺激胰岛素的分泌和降低食欲。它是最常给肥胖症或超重患者开的药物。
真人秀节目《为百万富翁做媒》(The Millionaire Matchmaker)的制片人和明星帕蒂·斯坦格对《华尔街日报》表示:“这种药物在好莱坞很流行。我身边的人都在服用。”
美国食品药品管理局(FDA)尚未批准Ozempic用于减肥,但人们却依旧能够买到这种药物。如果没有保险,这种药一个月用量的费用约为900美元。同类药物Wegovy已被批准用于减肥,如果没有保险,28天用量的费用超过1,300美元。
埃隆·马斯克在10月发推文称,他正在服用Wegovy和断食减肥。几个与前,他赤裸上身与肌肉发达的明星经纪人阿里·伊曼纽尔并排站在游艇上的照片曝光,这让他经历了一番肥胖羞辱。
翻译:刘进龙
审校:汪皓
Wait, Mark Zuckerberg is ripped? Isn’t he the scrawny CEO who famously invented Facebook from the Harvard dorm room that he seemingly never left?
Not anymore. The obsession with being fit and thin in the workplace is on the rise, with tech moguls like Zuckerberg and Jeff Bezos showing off their washboard abs, and the use of drugs like Ozempic for weight loss becoming increasingly common dinner conversation. At the same time, a range of studies and statistics show that discrimination against individuals on account of their weight prevails.
The dichotomy of obsessive fitness behaviors and weight discrimination illuminates how “fatphobia”—the aversion, hostility, or disdain for people who are overweight—persists, resulting in unequal opportunities for success in the workplace.
Roughly 42% of people in the U.S. are obese, according to the Centers for Disease Control and Prevention, and a new paper published in the American Journal of Public Health compares the prevalence of weight discrimination in the U.S. to that of racial discrimination.
Weight discrimination affects women the most in the workplace: 11% of human resource executives said applicants’ weight had been a factor in their decision to hire them, the Wall Street Journal reported in July on a spring survey. Women considered obese earn $5.25 less per hour than women considered a normal weight, according to a 2014 Vanderbilt University study.
The weight-wage penalty is less consistent among men, but across the board, employees who are overweight or obese are paid less and more often overlooked for promotions.
State and city governments are taking action to reduce its effects in the workplace.
The stigma around weight
Obesity is a medical condition, considered a disease by many organizations, involving having too much body fat. Obesity increases the risk for other diseases and health problems like heart disease, diabetes, and certain types of cancer, according to Mayo Clinic.
There are many reasons a person may have trouble losing weight. Some are genetically predisposed to obesity, while others have underlying health conditions that cause them to gain weight.
Still, fatphobia runs rampant. People with obesity are often blamed for their weight and are stigmatized as lazy or lacking in willpower. And the common perception persists that body shaming can be justified if it motivates people to adopt healthier behaviors.
New York City passed a bill in May, banning weight and height discrimination in employment opportunities, housing opportunities, and access to public accommodations, alongside race, gender, age, religion, and sexual orientation. The new law will go into effect in November 2023.
“It shouldn’t matter how tall you are or how much you weigh when you’re looking for a job, are out on the town, or trying to rent an apartment,” New York City Mayor Eric Adams said at a bill-signing ceremony. “This law will help level the playing field for all New Yorkers, create more inclusive workplaces and living environments, and protect against discrimination.”
Similar bills are being considered in New Jersey and Massachusetts. Michigan, Washington State, and some cities like Washington, D.C., already prohibit it.
Buff CEOs and Ozempic
Meanwhile, over-the-hill leaders in the corporate sector are setting a standard of physical fitness difficult to achieve without major resources.
“I think the pandemic and work from home really created the opportunity for C-suite executives to focus on their fitness,” Mark Cuban, a businessman and owner of the Dallas Mavericks, told the Wall Street Journal.
Forget yachts and Rolexes. The ability to squeeze a workout into an already packed schedule may be the new bragging rights, Cuban said.
For instance, Meta cofounder and CEO Mark Zuckerberg took up the martial art of Brazilian jujitsu during the pandemic, winning gold and silver medals at a tournament in May.
More recently, he participated in the Murph Challenge on Memorial Day, named after a Navy SEAL who was killed in action in Afghanistan. The workout entails wearing a 20-pound weighted vest and completing 100 pull-ups, 200 push-ups, 300 squats, and a mile-long run.
Zuckerberg finished the challenge in under 40 minutes. Then he told his 12.3 million followers about it on Instagram.
Other tech and finance elites and Hollywood celebrities are using certain drugs to promote weight loss.
The most popular of these is Ozempic, a drug used to help lower blood sugar in people with Type 2 diabetes. Ozempic contains an ingredient called semaglutide, which stimulates insulin production and reduces appetite. It is most often prescribed for people who are obese or overweight.
“This is a Hollywood drug,” Patti Stanger, star and producer of reality show The Millionaire Matchmaker, told the Wall Street Journal. “Everybody I know is on it,” she added.
The FDA has not approved Ozempic for weight loss, but people are getting their hands on it nonetheless. Without insurance, the drug costs about $900 a month. Its sister drug, Wegovy, has been approved for weight loss and without insurance costs over $1,300 for a 28-day supply.
Elon Musk tweeted in October that he was taking Wegovy and fasting in order to lose weight. A few months earlier, he had experienced an onslaught of fat shaming after a picture of him surfaced, standing shirtless on his yacht next to muscular celebrity talent agent Ari Emanuel.